Sandomierskie Stowarzyszenie Miłośników Motocykli

[bristy512]

DoseMe , a leading provider of model-informed precision dosing (MIPD) solutions, announced in July 2024 the expansion of its agreement with Dot.Lib as a partner in Argentina razil Chile Colombia Costa Rica, Mexico, Panama, Paraguay, Uruguay and other Latin American countries, as well as Portugal and Spain.

Since Dot.Lib has been a website development service leading provider of scientific information solutions for the Healthcare sector, dedicated to empowering academic, corporate and government institutions in Latin America and the Iberian Peninsula with access to high-quality digital resources.

“The two companies have a partnership that began in 2019 and its continued partnership will help advance education and growth in the practice of therapeutic medication monitoring (TDM), which has evolved into an important tool,” said Paul Edwards, CEO of DoseMe . “Our real-world data shows that the transition from traditional dosing to precision dosing helps inform decision-making for healthcare professionals, ultimately improving the patient journey.”



The results reported in the article " Switching Vancomycin Monitoring From Trough Concentration to Area Under the Curve Estimation by Bayesian Forecasting: A Short Communication on a Cost-Benefit Study in Resource-Limited Settings " and recently published in the journal Therapeutic Drug Monitoring are significant.

Led by João Paulo Marochi Telles, Diógenes Coelho, Karen Migotto, Rodrigo Reghini, Pedro Caruso and Ivan Leonardo França e Silva, from Hospital AC Camargo Cancer Center, the study shows how the Bayesian vancomycin adjustment protocol , using software, brings important cost-benefit results. This is particularly relevant in resource-limited settings, as the reduction in laboratory expenses may outweigh the costs of the software.

“In the precision dosing space, we have partnered with DoseMe to offer best-in-class software and services to help increase clinical pharmacist and physician efficiency, reduce costs and ultimately improve patient outcomes,” said Humberto Marcolini, Dot.Lib’s regional sales manager for Portugal and Spain. “We are able to demonstrate why DoseMeRx is the industry’s leading population-based precision dosing platform. Renewing the agreement is the right thing for us and the healthcare organizations we serve now and in the future.”

Dot.Lib offers a wide range of curated databases, e-journals, e-books, and other digital solutions from top-tier providers around the world. These resources ensure that physicians, pharmacists, nurses, and other healthcare professionals have access to the most relevant research, tools, and technologies in their respective fields.

DoseMe combines intelligent technology with science, using clinically validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO, and FDA compliant and is the only HITRUST CSF certified Bayesian dosing platform. Learn about successful use cases for DoseMeRx and DoseMe Analytics .

To learn more about how DoseMeRx can help your institution, contact us at or fill out the form by clicking here . For more content like this, follow our blog and follow us on our social networks and subscribe to Dotlib TV , Dot.Lib's official YouTube channel!
_________________
website development service

[Reklama]